Study of Peripheral Neuropathy in Patients With Advanced Urothelial Cancer Treated With Enfortumab Vedotin and Pembrolizumab With Supportive Neuridase (ENDEAVOR)
Conditions
- Urothelial Carcinoma (UC)
- Peripheral Nerve Disease
Interventions
- DRUG: enfortumab vedotin (EV)
- DRUG: PEMBROLIZUMAB (alone or when added to a regimen above)
- OTHER: Neuridase
Sponsor
University of Florence
Collaborators